A strategic approach to global regulatory compliance for medical devices
Taking a strategic approach to achieving regulatory approval can be an effective tool in reducing the compliance burden facing medical device manufacturers. Companies that first obtain approval or clearance from the US Food and Drug Administration (FDA) for access to the US market can often leverage that clearance or approval to gain a prompt and efficient review of new device applications by regulators in other markets. This can result in faster and wider deployment of new medical technologies and help generate increased revenue from the sale of new medical devices faster.
To access the rest of this engaging content, please fill out the form below:
Related resources
- Optimizing a QMS for Medical Device Companies
- The Global Aspect of Essential Principles for Medical Device Regulation
- Global Impact of (EU) Regulation 2023/607
- What is the IMDRF Regulated Product Submission for Medical Devices?
- Guidance on European MDR Extension, MDR and IVDR Sell-off Period Deletion
- UK MHRA Has Published Details on How to Manage Leveraging EU Compliance
- RADAR : Market Access Newsletter